We are live on ! Find out more
B

Bellecapital Portfolio holdings

AUM $554M
1-Year Est. Return 29.39%
This Fund
S&P 500
This Quarter Est. Return
+7.59%
1 Year Est. Return
+29.39%
3 Year Est. Return
+99.7%
5 Year Est. Return
+120.39%
10 Year Est. Return
+406.87%
AUM
$153M
AUM Growth
+$14M
Cap. Flow
+$5.17M
Cap. Flow %
3.39%
Top 10 Hldgs %
43.38%
Holding
102
New
13
Increased
21
Reduced
25
Closed
17

Sector Composition

1 Consumer Discretionary 14.83%
2 Technology 14.32%
3 Communication Services 11.75%
4 Healthcare 8.63%
5 Financials 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFA icon
51
iShares MSCI EAFE ETF
EFA
$76.5B
$524K 0.34%
+7,704
New +$520K
GOOG icon
52
Alphabet (Google) Class C
GOOG
$4.22T
$517K 0.34%
8,660
-520
-6% -$31.1K
ABB
53
DELISTED
ABB Ltd
ABB
$505K 0.33%
21,365
INTC icon
54
Intel
INTC
$478B
$503K 0.33%
10,626
+1,266
+14% +$61.6K
PG icon
55
Procter & Gamble
PG
$349B
$499K 0.33%
6,000
+310
+5% +$25.4K
RDS.A
56
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$494K 0.32%
7,251
EZU icon
57
iShare MSCI Eurozone ETF
EZU
$9.41B
$475K 0.31%
+11,581
New +$480K
UBS icon
58
UBS Group
UBS
$173B
$462K 0.3%
29,402
+275
+0.9% +$4.32K
IBDL
59
DELISTED
iShares iBonds Dec 2020 Term Corporate ETF
IBDL
$415K 0.27%
16,580
JNJ icon
60
Johnson & Johnson
JNJ
$609B
$414K 0.27%
2,994
+100
+3% +$13.3K
EWU icon
61
iShares MSCI United Kingdom ETF
EWU
$4.02B
$409K 0.27%
12,000
IBDN
62
DELISTED
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
$404K 0.26%
16,615
BA icon
63
Boeing
BA
$169B
$380K 0.25%
1,023
NVS icon
64
Novartis
NVS
$293B
$367K 0.24%
4,755
+409
+9% +$30.2K
TEVA icon
65
Teva Pharmaceuticals
TEVA
$37.3B
$345K 0.23%
16,000
SAN icon
66
Banco Santander
SAN
$194B
$340K 0.22%
71,003
+9,957
+16% +$50.1K
META icon
67
Meta Platforms (Facebook)
META
$1.64T
$334K 0.22%
2,028
+70
+4% +$12.7K
JPM icon
68
JPMorgan Chase
JPM
$907B
$324K 0.21%
2,871
BRK.A icon
69
Berkshire Hathaway Class A
BRK.A
$1.06T
$320K 0.21%
1
LLY icon
70
Eli Lilly
LLY
$1.05T
$279K 0.18%
2,602
VCSH icon
71
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.8B
$275K 0.18%
3,520
+390
+12% +$30.5K
AXJL
72
DELISTED
WisdomTree Asia-Pacific ex-Japan Fund
AXJL
$271K 0.18%
4,004
SHY icon
73
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
$270K 0.18%
+3,253
New +$271K
IEF icon
74
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$269K 0.18%
+2,659
New +$271K
EWL icon
75
iShares MSCI Switzerland ETF
EWL
$2.01B
$249K 0.16%
+7,188
New +$246K

Similar funds

Bellecapital's Q3 2018 Portfolio in Review

As of Q3 2018, Bellecapital held 102 positions worth $153M, up 10% from $138M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Bellecapital deployed $5.17M of net new capital in Q3 2018, opening 13 new positions and adding to 21 existing holdings. Its largest new stake was Salesforce: 14,895 shares worth $2.37M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, down from 16% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iShares Biotechnology ETF, an estimated $833K trimmed.

  • Bellecapital's largest Q3 2018 buy was Salesforce: 14,895 shares worth $2.37M.
  • Bellecapital added most to Coca-Cola in Q3 2018, an estimated $6.13M increase.
  • Bellecapital's biggest Q3 2018 reduction was iShares Biotechnology ETF, cutting an estimated $833K.
  • Bellecapital fully exited SLB Ltd in Q3 2018, selling an estimated $3.48M.
  • Bellecapital's ten largest holdings make up 43% of its $153M portfolio in Q3 2018.
  • Bellecapital opened 13 new positions and closed 17 in Q3 2018.
  • Bellecapital's portfolio value rose 10% quarter-over-quarter to $153M.

Based on Bellecapital's 13F filing for Q3 2018, filed 12 Oct 2018.